Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Free Cash Flow: 2016-2024

Historic Free Cash Flow for Arcus Biosciences (RCUS) over the last 9 years, with Dec 2024 value amounting to -$176.0 million.

  • Arcus Biosciences' Free Cash Flow fell 488.00% to -$97.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$464.0 million, marking a year-over-year decrease of 174.56%. This contributed to the annual value of -$176.0 million for FY2024, which is 46.67% up from last year.
  • Per Arcus Biosciences' latest filing, its Free Cash Flow stood at -$176.0 million for FY2024, which was up 46.67% from -$330.0 million recorded in FY2023.
  • In the past 5 years, Arcus Biosciences' Free Cash Flow ranged from a high of $432.0 million in FY2022 and a low of -$330.0 million during FY2023.
  • In the last 3 years, Arcus Biosciences' Free Cash Flow had a median value of -$176.0 million in 2024 and averaged -$24.7 million.
  • In the last 5 years, Arcus Biosciences' Free Cash Flow tumbled by 361.11% in 2021 and then surged by 253.19% in 2022.
  • Over the past 5 years, Arcus Biosciences' Free Cash Flow (Yearly) stood at $108.0 million in 2020, then slumped by 361.11% to -$282.0 million in 2021, then skyrocketed by 253.19% to $432.0 million in 2022, then tumbled by 176.39% to -$330.0 million in 2023, then spiked by 46.67% to -$176.0 million in 2024.